The Health Secretary, Wes Streeting, recently expressed his disappointment in the Conservative government for squandering what he referred to as a “golden inheritance” left by Tony Blair’s Labour government for the NHS. It was highlighted that the NHS under Labour had achieved the lowest waiting times and the highest patient satisfaction in its history. However,
0 Comments
CAR T-cell therapy has been a revolutionary advancement in cancer treatment, offering new hope to patients with refractory or relapsed malignancies. However, recent concerns have been raised regarding the incidence of second primary malignancies (SPM) associated with this therapy. A systematic literature review and meta-analysis aimed to evaluate the risk of SPM with CAR T-cell
0 Comments